Transcranial Doppler cerebrovascular reactivity: Thresholds for clinical significance in cerebrovascular disease.
CO2 reactivity
arterial stenosis
cerebrovascular disease
cerebrovascular reactivity
ischemic stroke
transcranial Doppler
vasomotor range
Journal
Journal of neuroimaging : official journal of the American Society of Neuroimaging
ISSN: 1552-6569
Titre abrégé: J Neuroimaging
Pays: United States
ID NLM: 9102705
Informations de publication
Date de publication:
30 Mar 2024
30 Mar 2024
Historique:
revised:
04
03
2024
received:
11
01
2024
accepted:
07
03
2024
medline:
30
3
2024
pubmed:
30
3
2024
entrez:
30
3
2024
Statut:
aheadofprint
Résumé
Thresholds for abnormal transcranial Doppler cerebrovascular reactivity (CVR) studies are poorly understood, especially for patients with cerebrovascular disease. Using a real-world cohort with cerebral arterial stenosis, we sought to describe a clinically significant threshold for carbon dioxide reactivity (CO2R) and vasomotor range (VMR). CVR studies were performed during conditions of breathing room air normally, breathing 8% carbon dioxide air mixture, and hyperventilation. The mean and standard deviation (SD) of CO2R and VMR were calculated for the unaffected side in patients with unilateral stenosis; a deviation of 2 SDs below the mean was chosen as the threshold for abnormal. Receiver operating characteristic (ROC) curves for both sides for patients with unilateral and bilateral stenosis were evaluated for sensitivity (Sn) and specificity (Sp). A total of 133 consecutive CVR studies were performed on 62 patients with stenosis with mean±SD age 55±16 years. Comorbidities included hypertension (60%), diabetes (15%), stroke (40%), and smoking (35%). In patients with unilateral stenosis, mean±SD CO2R for the unaffected side was 1.86±0.53%, defining abnormal CO2R as <0.80%. Mean±SD CO2R for the affected side was 1.27±0.90%. The CO2R threshold predicted abnormal acetazolamide single-photon emission computed tomography (SPECT) (Sn = .73, Sp = .79), CT/MRI perfusion abnormality (Sn = .42, Sp = .77), infarction on MRI (Sn = .45, Sp = .76), and pressure-dependent exam (Sn = .50, Sp = .76). For the unaffected side, mean±SD VMR was 39.5±15.8%, defining abnormal VMR as <7.9%. For the affected side, mean±SD VMR was 26.5±17.8%. The VMR threshold predicted abnormal acetazolamide SPECT (Sn = .46, Sp = .94), infarction on MRI (Sn = .27, Sp = .94), and pressure-dependent exam (Sn = .31, Sp = .90). In patients with multiple vascular risk factors, a reasonable threshold for clinically significant abnormal CO2R is <0.80% and VMR is <7.9%. Noninvasive CVR may aid in diagnosing and risk stratifying patients with stenosis.
Sections du résumé
BACKGROUND AND PURPOSE
OBJECTIVE
Thresholds for abnormal transcranial Doppler cerebrovascular reactivity (CVR) studies are poorly understood, especially for patients with cerebrovascular disease. Using a real-world cohort with cerebral arterial stenosis, we sought to describe a clinically significant threshold for carbon dioxide reactivity (CO2R) and vasomotor range (VMR).
METHODS
METHODS
CVR studies were performed during conditions of breathing room air normally, breathing 8% carbon dioxide air mixture, and hyperventilation. The mean and standard deviation (SD) of CO2R and VMR were calculated for the unaffected side in patients with unilateral stenosis; a deviation of 2 SDs below the mean was chosen as the threshold for abnormal. Receiver operating characteristic (ROC) curves for both sides for patients with unilateral and bilateral stenosis were evaluated for sensitivity (Sn) and specificity (Sp).
RESULTS
RESULTS
A total of 133 consecutive CVR studies were performed on 62 patients with stenosis with mean±SD age 55±16 years. Comorbidities included hypertension (60%), diabetes (15%), stroke (40%), and smoking (35%). In patients with unilateral stenosis, mean±SD CO2R for the unaffected side was 1.86±0.53%, defining abnormal CO2R as <0.80%. Mean±SD CO2R for the affected side was 1.27±0.90%. The CO2R threshold predicted abnormal acetazolamide single-photon emission computed tomography (SPECT) (Sn = .73, Sp = .79), CT/MRI perfusion abnormality (Sn = .42, Sp = .77), infarction on MRI (Sn = .45, Sp = .76), and pressure-dependent exam (Sn = .50, Sp = .76). For the unaffected side, mean±SD VMR was 39.5±15.8%, defining abnormal VMR as <7.9%. For the affected side, mean±SD VMR was 26.5±17.8%. The VMR threshold predicted abnormal acetazolamide SPECT (Sn = .46, Sp = .94), infarction on MRI (Sn = .27, Sp = .94), and pressure-dependent exam (Sn = .31, Sp = .90).
CONCLUSIONS
CONCLUSIONS
In patients with multiple vascular risk factors, a reasonable threshold for clinically significant abnormal CO2R is <0.80% and VMR is <7.9%. Noninvasive CVR may aid in diagnosing and risk stratifying patients with stenosis.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIH HHS
Pays : United States
Organisme : NINDS NIH HHS
ID : R25 NS065743
Pays : United States
Informations de copyright
© 2024 American Society of Neuroimaging.
Références
Chimowitz MI, Lynn MJ, Derdeyn CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365:993–1003.
Derdeyn CP, Chimowitz MI, Lynn MJ, et al. Aggressive medical treatment with or without stenting in high‐risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet. 2014;383:333–341.
Gao P, Wang D, Zhao Z, et al. Multicenter prospective trial of stent placement in patients with symptomatic high‐grade intracranial stenosis. Am J Neuroradiol. 2016;37:1275–1280.
Yu W, Jiang WJ. Stenting for intracranial stenosis: potential future for the prevention of disabling or fatal stroke. Stroke Vasc Neurol. 2018;3:140–146.
Powers WJ, Clarke WR, Grubb RL, et al. Extracranial‐intracranial bypass surgery for stroke prevention in hemodynamic cerebral ischemia: the carotid occlusion surgery study randomized trial. JAMA—J Am Med Assoc. 2011;306:1983–1992.
Grubb RL, Powers WJ, Clarke WR, et al. Surgical results of the carotid occlusion surgery study: clinical article. J Neurosurg. 2013;118:25–33.
Saber H, Rajah G, Palla M, et al. Utilization and safety of extracranial–intracranial bypass surgery in symptomatic steno‐occlusive disorders. Brain Circ. 2019;5:32–35.
Regenhardt RW, Das AS, Stapleton CJ, et al. Blood pressure and penumbral sustenance in stroke from large vessel occlusion. Front Neurol. 2017;8:317.
Bishop CCR, Powell S, Rutt D, et al. Transcranial doppler measurement of middle cerebral artery blood flow velocity: a validation study. Stroke. 1986;17:913–915.
Marshall RS, Rundek T, Sproule DM, et al. Monitoring of cerebral vasodilatory capacity with transcranial Doppler carbon dioxide inhalation in patients with severe carotid artery disease. Stroke. 2003;34:945–949.
Carrera E, Kurtz P, Badjatia N, et al. Cerebrovascular carbon dioxide reactivity and delayed cerebral ischemia after subarachnoid hemorrhage. Arch Neurol. 2010;67:434–439.
Ringelstein EB, Grosse W, Matentzoglu S, et al. Non‐invasive assessment of the cerebral vasomotor reactivity by means of transcranial doppler sonography during hyper‐ and hypocapnea. Klin Wochenschr. 1986;64:194–195.
Bernd Ringelstein E, Sievers C, Ecker S, et al. Noninvasive assessment of CO2‐induced cerebral vasomotor response in normal individuals and patients with internal carotid artery occlusions. Stroke. 1988;19:963–979.
Markus HS, Harrison MJG. Estimation of cerebrovascular reactivity using transcranial doppler, including the use of breath‐holding as the vasodilatory stimulus. Stroke. 1992;23:668–673.
Campos Herrera CR, Beltramini GC, Avelar WM, et al. Cerebral vasomotor reactivity assessment using transcranial doppler and MRI with apnea test. Brazilian J Med Biol Res. 2016;49:e5437.
Latchaw RE, Yonas H, Hunter GJ, et al. Guidelines and recommendations for perfusion imaging in cerebral ischemia: a scientific statement for healthcare professionals by the Writing Group on Perfusion Imaging, from the Council on Cardiovascular Radiology of the American Heart Association. Stroke. 2003;34:1084–1104.
Leung J, Behpour A, Sokol N, et al. Assessment of intracranial blood flow velocities using a computer controlled vasoactive stimulus: a comparison between phase contrast magnetic resonance angiography and transcranial doppler ultrasonography. J Magn Reson Imaging. 2013;38:733–738.
Taylor DW, Haynes RB, Sackett DL, et al. Beneficial effect of carotid endarterectomy in symptomatic patients with high‐grade carotid stenosis. N Engl J Med. 1991;325:445–453.
Samuels OB, Joseph GJ, Lynn MJ, et al. A standardized method for measuring intracranial arterial stenosis. Am J Neuroradiol. 2000;21:643–646.
Chimowitz MI, Lynn MJ, Howlett‐Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352:1305–1316.
Bangert SK, Marshall WJ. Clinical biochemistry: metabolic and clinical aspects. Philadelphia, PA: Churchill Livingstone Elsevier; 2008.
Ceriotti F, Henny J. “Are my laboratory results normal?” Considerations to be made concerning reference intervals and decision limits. EJIFCC. 2008;19:106–114.